Skip to content

Exagen Inc. XGN Reportable Segment — Gross Profit

Similar metrics at other companies

XPEL, Inc. logo
XPELReportable Segment — Gross Profit
$51.23M+16.7%
The RealReal logo
REALReportable Segment — Gross Profit
$141.33M+17.8%
ITG
ITGRReportable Segment — Gross Profit
$125.1M+9.0%
Marqeta logo
MQReportable Segment — Gross Profit
$117.59M+19.2%
Energy Vault Holdings logo
NRGVReportable Segment — Gross Profit
$4.79M-1.8%
Coursera logo
COURReportable Segment — Gross Profit
$128.7M+11.3%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:GrossProfit.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s reportable segment — gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s reportable segment — gross profit?
Exagen Inc. (XGN) reported reportable segment — gross profit of $10.21M in Q1 2026.
How has Exagen Inc.'s reportable segment — gross profit changed year-over-year?
Exagen Inc.'s reportable segment — gross profit increased by 11.9% year-over-year, from $9.12M to $10.21M.
What is the long-term trend for Exagen Inc.'s reportable segment — gross profit?
Over 2 years (2023 to 2025), Exagen Inc.'s reportable segment — gross profit has grown at a 14.8% compound annual growth rate (CAGR), from $29.46M to $38.8M.
What does reportable segment — gross profit mean?
Calculated as the segment's revenue minus its direct cost of revenue, representing the core profitability of the diagnostic testing business before operating expenses. This metric highlights the segment's pricing power and the efficiency of its diagnostic service delivery model.